Concepedia

Boris Decourt

BD

Statistics

Publications

15

Citations

459

H-Index

14

Active since

2002

Affiliations

Banner Sun Health Research Institute(Current)

Barrow Neurological Institute

Purdue University West Lafayette

Arizona State University

Lou Ruvo Brain Institute

Boris Decourt is an author at Banner Sun Health Research Institute specializing in life sciences, neurodegenerative diseases, and alzheimer disease.

ORCID

Publications per year

2002–2022

15

Publications

15

Inhibition of rat liver fibrogenesis through noradrenergic antagonism

L Dubuisson, Alexis Desmoulière, Boris Decourt et al. · Hepatology · 2002 · 82 citations · Full text

, , +17

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial

Boris Decourt, Denise Drumm-Gurnee, Jeffrey R. Wilson et al. · Current Alzheimer Research · 2017 · 54 citations · Full text

, , +17

Src and cortactin promote lamellipodia protrusion and filopodia formation and stability in growth cones

Yingpei He, Yuan Ren, Bingbing Wu et al. · Molecular Biology of the Cell · 2015 · 51 citations

, , +17

COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer disease

Marwan N. Sabbagh, Boris Decourt · Expert Opinion on Investigational Drugs · 2022 · 42 citations · Full text

, , +17

<p>MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease</p>

Boris Decourt, Jeffrey S. Wilson, Aaron Ritter et al. · Open Access Journal of Clinical Trials · 2020 · 40 citations · Full text

, , +17

1–5 of 15